Clinical trial NCT05882786: Corticosteroid Injection Versus Tendon Dry Needling for Subacromial Impingement Syndrome
Official title: Comparing the Efficacy of Corticosteroid Injection and Tendon Dry Needling for Subacromial Impingement Syndrome: A Randomized Clinical Trial
Study type: INTERVENTIONAL
Overall status: UNKNOWN
Phase: NA
Conditions: Shoulder Pain
Shoulder Impingement Syndrome
Shoulder Impingement
Subacromial Impingement Syndrome
Subacromial Impingement
Lead sponsor: Uskudar State Hospital
Sponsor class: OTHER_GOV
First posted: 2023-05-31
Enrollment: 60
Sex: ALL
Minimum age (years): 18
Maximum age (years): 65
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Intervention model description: Randomized controlled trial
Primary purpose: TREATMENT

Brief summary: This randomized clinical trial aims to compare the efficacy of corticosteroid injection and tendon dry needling for the treatment of subacromial impingement syndrome.

Detailed description: This randomized clinical trial will compare the efficacy of corticosteroid injection and tendon dry needling for the treatment of subacromial impingement syndrome.Participants will be randomized to receive either a corticosteroid injection or tendon dry needling treatment. The corticosteroid injection group will receive a single subacromial injection of 40mg triamcinolone acetonide under ultrasound guidance. The tendon dry needling group will receive a total of 3 sessions of dry needling treatment to the supraspinatus, infraspinatus, and subscapularis muscle tendons. Patients will be assessed before treatment, after treatment, after three weeks and after three months with visual analog scale, Shoulder Pain and Disability Index (SPADI) and shoulder range of motion measurements.

Eligibility criteria: Inclusion Criteria:

* Adult patients aged 18-65 years old
* Diagnosis of subacromial impingement syndrome, confirmed by clinical examination and imaging (such as X-ray or MRI)
* Moderate to severe shoulder pain, with a score of at least 4 on a 0-10 visual analog scale (VAS) for pain
* Willingness to comply with the study protocol and attend all study visits and assessments
* Ability to provide informed consent to participate in the study.

Exclusion Criteria:

* Contraindications to corticosteroid injection or dry needling, such as local infection, bleeding disorders, or allergy to the injectate or needle
* Previous shoulder surgery on the affected shoulder
* Other active shoulder conditions, such as rotator cuff tear or adhesive capsulitis, that may confound the study results
* Systemic conditions, such as rheumatoid arthritis or osteoarthritis, that may affect the shoulder joint and its function
* History of shoulder dislocation or instability
* Pregnancy or breastfeeding
* Current use of systemic corticosteroids or immunosuppressive drugs
* Injection to shoulder area in the past six months.
* Inability to complete the study assessments or follow the study protocol, such as due to cognitive impairment or language barrier.

Primary outcomes:
measure: Change in Visual Analog Scale for Pain
timeFrame: First day, after three weeks, after three months
measure: Change in The Shoulder Pain and Disability Index (SPADI)
timeFrame: First day, after three weeks, after three months
measure: Change in Range Of Motion (ROM) Measurements
timeFrame: First day, after three weeks, after three months
Secondary outcomes:
Other outcomes:
Locations:
Study officials:
affiliation: Uskudar State Hospital
name: Mustafa H Temel, M.D.
role: PRINCIPAL_INVESTIGATOR
References: